In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

3rd CRISPR 2.0 Summit 2022

Nov 29, 2022 - 08:30 AM - Dec 01, 05:00 PM
Hanson Wade
Hilton Boston Back Bay
40, Dalton St

ZIP: 02115
Phone: +16174554188

Ticket Price: USD 2499.00 - USD 4897.00

Recognised with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and innovative delivery platforms.

The CRISPR 2.0 Summit is devoted to showcasing only the latest and greatest innovations by uncovering how the next generation of CRISPR tools are radically enhancing efficacy, minimizing off-target effects and enabling efficient tissue-specific delivery to help you progress your program into and through the clinic.

Across three days of content, carefully co-designed with industry thought leaders, this streamlined one-track summit will unite key players in the CRISPR space, from large pharma to ground-breaking biotech, academics to exciting service providers, all with the purpose of paving a way forward to market for your CRISPR gene editing program.

Brochure: https://go.evvnt.com/1278515-2?pid=1052
Tickets: https://go.evvnt.com/1278515-3?pid=1052

FULL PACKAGE: Conference + Workshop Day - Physical - Drug Developer: USD 4097.00,
Conference Only - Physical - Drug Developer: USD 2899.00,
FULL PACKAGE: Conference + Workshop Day - Physical - Academic: USD 3497.00,
Conference Only - Physical - Academic: USD 2499.00,
FULL PACKAGE: Conference + Workshop Day - Physical - Solution Provider: USD 4897.00,
Conference Only - Physical - Solution Provider: USD 3499.00

Speaker Details

Aditya Raguram, PhD Student  David Liu Lab, Harvard University, Alexandra Crawley, Co-Founder and Senior Scientist, LifeEDIT, Amy Simon, Chief Medical Officer,  Beam Therapeutics, Benjamin Oakes, Co-Founder and Chief Executive Officer, Scribe Therapeutics, Carlo Zambonelli, Senior Director - Analytical Sciences, Beam Therapeutics, Danilo Maddalo, Group Leader - Translational Oncology, Genentech, David Guay, Vice President Innovation and Technology, Feldan Therapeutics, Eric B. Kmiec, Executive Director and Chief Scientific Officer,  ChristianaCare Gene Editing Institute, Guillaume Pavlovic, Head of Genetic Engineering and Model Validation Department, Institut Clinique De La Souris, Howard Wu, Founder and Chief Scientific Officer, Full Circles Therapeutics, Inge Yung-Chih Cheng, Principal Scientist, Pfizer, Ira Gotliv, Vice President - Preclinical Research, Emendo Biotherapeutics, Jane Grogan, Chief Scientific Officer, Graphite Bio, Jeremy Duffield, Chief Scientific Officer, Prime Medicine, Joey Riepsaame, Head of Genome Engineering, University of Oxford, John Murphy, Chief Scientific Officer, Arbor Biotechnologies, Jonathan Yen, Director of Therapeutic Genome Engineering, St. Jude Children's Research Hospital, Kiran Musunuru, Professor of Medicine Director, Perelman School of Medicine, University of Pennsylvania, Liron Walsh, Head of Development; In Vivo Programs, Intellia Therapeutics, Paul Donohue, Senior Scientist - Platform Discovery Group Lead, Caribou Biosciences, Rafi Emmanuel, Senior Vice President - Research and Development, Emendo Biotherapeutics, Rajarshi Choudhury ,Associate Director - Genomic Sciences, GSK, Rammohan Devulapally, Principal Scientist - Drug Delivery Chemistry and Nanoparticle Formulation Development, GenEdit, Roberto Nitsch, Associate Director, AstraZeneca, Samuel Du MD-PhD, Student, Krzysztof Palczewski Lab, University of California Irvine, Weston Miller, Vice President - Clinical Development, Graphite Bio

Event Categories
Keywords: conference


Events Calendar

30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3

Event Location


VIP Life Time Subscription to our Newsletters!